C12R 2001/625
Streptoverticillium
C12R2001/625 (Streptoverticillium) appears on 14 US grants and 0 published applications in this corpus.
Search patents in C12R- Granted patents
- 14
- Published applications
- 0
- Assignees
- 9
- Inventors
- 46
- Latest grant
- 1 Mar 1994
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1981 | 1 | 0 |
| 1982 | 2 | 0 |
| 1983 | 0 | 0 |
| 1984 | 2 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 2 | 0 |
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 2 | 0 |
| 1994 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Streptoverticillium ferm P-10489 which produces antitumor agent BE-13793C1 Mar 1994US 5,290,698 ABanyu Pharmaceutical Co., Ltd.
- Antitumor substance BE-13793C8 Jun 1993US 5,217,885 ABanyu Pharmaceutical Co., Ltd.
- Oasomycins23 Feb 1993US 5,189,150 AHoechst Aktiengesellschaft
- Antitumor substance BE-13793C21 Apr 1992US 5,106,864 ABanyu Pharmaceutical Co., Ltd.
- FR-900848 substance and preparation thereof7 Feb 1989US 4,803,074 AFujisawa Pharmaceutical Co., Ltd.
No published applications in this class yet.
Most cited
By later US patents
- Antitumor substance BE-13793C10US 5,106,864 ABanyu Pharmaceutical Co., Ltd. · 1992
- Dopamine .beta.-hydroxylase inhibitors6US 4,487,761 AMerck & Co., Inc. · 1984
- Pentadecapeptide4US 4,452,782 AHoffmann-La Roche Inc. · 1984
- Antibiotic LL-BO1208.alpha. and LL-BO1208.beta., process of preparation, pharmaceutical composition and method of use4US 4,552,867 AAmerican Cyanamid Company · 1985
- Antitumor substance BE-13793C4US 5,217,885 ABanyu Pharmaceutical Co., Ltd. · 1993